BlueRock Therapeutics ULC


101 College Street, Suite 15-701, East Tower

Toronto, ON, M5G 1L7


Member Sector: Biopharmaceuticals

Driven by a vision to liberate patients from the burden of degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicine that repairs the body when it can no longer repair itself. Founded in 2016 through one of the largest Series A financings in biotech history, BlueRock and its team of preeminent scientists are pioneering cell therapies that replace dead, damaged or dysfunctional cells to restore critical natural functions in the body. Using an approach that can be applied to multiple diseases with great unmet need, BlueRock is initially targeting severe brain and heart conditions, with the goal of altering the course of disease and drastically improving quality of life. BlueRock’s culture is defined by scientific transparency, the highest ethical standards, and an urgency to bring transformative treatments to all who would benefit.